TLR9: Toll-like receptor 9
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Key component of innate and adaptive immunity.
- Drugs that act on it: 9
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Hydroxychloroquine | Approved | Toll-like receptor 9 antagonist | Antagonist | — |
| 1018 iss | — | Toll-like receptor 9 agonist | Agonist | — |
| Agatolimod | — | Toll-like receptor 9 agonist | Agonist | — |
| Bazlitoran | — | Toll-like receptor 9 antagonist | Antagonist | — |
| Cobitolimod | — | Toll-like receptor 9 agonist | Agonist | — |
| EMD-1201081 | — | Toll-like receptor 9 agonist | Agonist | — |
| Lefitolimod | — | Toll-like receptor 9 agonist | Agonist | — |
| Tilsotolimod | — | Toll-like receptor 9 agonist | Agonist | — |
| Tilsotolimod sodium | — | Toll-like receptor 9 agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Malaria
- 0.58
- COVID-19
- 0.44
- Cutaneous lupus erythematosus
- 0.43
- Non-small cell lung carcinoma
- 0.38
- Pneumonia
- 0.37
- Melanoma
- 0.36
- Breast cancer
- 0.33
- Pulmonary sarcoidosis
- 0.33
Drugs and mechanisms are from ChEMBL CHEMBL5804 (CC BY-SA 3.0). Gene name, function (UniProt Q9NR96, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets